Aug, 2, 2014 : Company Profiles and Conferences presents a Company Report on “Almirall, S.A. (ALM) – Financial and Strategic SWOT Analysis Review”, which helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
Almirall, S.A. (ALM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile is bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
– Business description A detailed description of the companys operations and business divisions.
– Corporate strategy Analysts summarization of the companys business strategy.
– SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
– Company history Progression of key events associated with the company.
– Major products and services A list of major products, services and brands of the company.
– Key competitors A list of key competitors to the company.
– Key employees A list of the key executives of the company.
– Executive biographies A brief summary of the executives employment history.
– Key operational heads A list of personnel heading key departments/functions.
– Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Almirall, S.A. (Almirall) is a pharmaceutical company. It carries out the research, development, manufacture and commercialization of proprietary medicines and licensed products. The company’s research led to the development of products such as Actikerall, Almax, Balneum. The companys products focus on treating respiratory diseases, including asthma and COPD; autoimmune diseases including rheumatoid arthritis and multiple sclerosis; dermatological diseases including psoriasis, eczema, acne and other skin infections; and gastrointestinal diseases including irritable bowel syndrome with constipation.
Almirall, S.A. Key Recent Developments
Oct 10, 2013: Almirall commercialises Neurofarmagen, an innovative genetic test
Sep 05, 2013: International pharmaceutical company, Almirall, expands global footprint with new Canadian affiliate
Jul 29, 2013: Almirall Reports Revenue Of 410.4m In H1 2013
Jul 03, 2013: Almirall maintains its commitment to the environment in Spain and Germany
Jun 19, 2013: Almirall, pioneer in Spain by being awarded the ISO 50001:2011 energy management system certification